Whole Body MRI Screening for Li-Fraumeni Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a Whole Body MRI (a type of imaging scan) can detect cancer early in individuals with certain genetic conditions that increase cancer risk. It focuses on those with Li-Fraumeni Syndrome (LFS) and other inherited cancer syndromes, which may involve a specific gene mutation or a strong family history of cancer. The trial suits individuals with these genetic conditions who are not currently battling active cancer. Participants must be in stable remission if they have had cancer before. The trial aims to improve early cancer detection and, consequently, treatment outcomes for these high-risk groups. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could lead to earlier cancer detection for those at high risk.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that Whole Body MRI is safe for screening?
Research has shown that whole-body MRI is a safe choice for people with Li-Fraumeni Syndrome (LFS). Because LFS patients are sensitive to radiation, MRI is recommended over scans that use radiation. Studies have found that whole-body MRI is effective for regular cancer checks in these individuals.
Screenings in Brazil and other research have demonstrated that whole-body MRI is easy for patients to handle, with no reports of major side effects. Experts recommend it for yearly exams to catch cancer early and improve long-term health.
In summary, whole-body MRI is considered safe, with no significant risks reported in past screenings. It is the preferred method for those at high risk of cancer due to its safety.12345Why are researchers excited about this trial?
Researchers are excited about whole body MRI screening for Li-Fraumeni Syndrome because it offers a non-invasive method to detect cancer early across the entire body. Unlike traditional imaging techniques, which may focus on specific areas, whole body MRI provides a comprehensive view, potentially catching cancers that might otherwise be missed. This method can be particularly beneficial for individuals with Li-Fraumeni Syndrome, who are at higher risk for multiple types of cancer, offering a proactive approach to monitoring their health.
What evidence suggests that Whole Body MRI is effective for screening cancer in Li-Fraumeni Syndrome?
Research has shown that Whole Body MRI scans, which participants in this trial will undergo, effectively detect cancer early in individuals with Li-Fraumeni Syndrome (LFS), a genetic condition that increases cancer risk. Studies have found that these scans can detect cancer in 7-16% of individuals with LFS during their first scan. In another study, Whole Body MRI detected 41 out of 46 cancers at an early stage, indicating a 6% detection rate. Additionally, Whole Body MRI identified 9 cancers in 54 people, a higher detection rate than typically seen in the general population. This evidence suggests that Whole Body MRI is a valuable tool for early cancer detection in individuals with inherited cancer risks like LFS.36789
Who Is on the Research Team?
Allison O'Neill, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for adults and children with Li-Fraumeni Syndrome or other inherited cancer predisposition syndromes. Participants must be in stable remission from any previous cancers, not pregnant, and able to give informed consent. It excludes those currently with active cancer (except certain types), pregnant/nursing women, and anyone with metal implants that affect MRI safety.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Whole Body MRI Scanning
Participants undergo Whole Body MRI scans to detect early-stage cancers
Follow-up
Participants are monitored for detection of prevalent and incident cancers
What Are the Treatments Tested in This Trial?
Interventions
- Whole Body MRI
Trial Overview
The study is testing the use of Whole Body MRI as a screening method to detect early-stage cancers in individuals who have genetic conditions that make them more likely to develop cancer, such as Li-Fraumeni Syndrome.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
* Magnetic resonance imaging will be performed on participants * Participants who are two young to tolerate the scans awake, can receive sedation/anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Citations
Evaluation of whole-body MRI for cancer early detection in ...
Other studies have reported outcomes from single baseline WB-MRI scans in individuals with LFS12 14 18 with cancer detection in 7–16% of ...
A prospective study of whole-body MRI (WBMRI) as part of ...
Results: 162 eligible participants (pts) with LFS (127 adult, 35 pediatric) underwent a total of 477 WBMRIs; 119 (73%) underwent 3 or more.
Baseline surveillance in Li Fraumeni syndrome using ...
Whole-body MRI identified 41 out of 46 cancers at an early stage, achieving an overall detection rate of 6%. Whole-body MRI surveillance is a valuable method ...
A prospective study of whole-body MRI (WBMRI) as part of ...
Conclusions: Annual WBMRI contributes substantially to detection of asymptomatic localized cancers among individuals with LFS but interval cancers remain common ...
1195P Whole-body magnetic resonance imaging (WB-MRI ...
Overall, 9 cancers in 54 individuals were diagnosed with the help of WB-MRI. The rate of cancers detected in this cohort was higher than expected in a general ...
Li-Fraumeni Syndrome and Whole-Body MRI Screening
Patients with LFS are very susceptible to radiation, therefore the use of whole-body MRI is recommended for regular cancer screening.
observations from a two rounds screening of Brazilian patients
The purpose of this study was to evaluate two rounds of whole-body magnetic resonance imaging (WB-MRI) which were conducted as a screening strategy for LFS ...
LFS Whole-Body MRI Consensus | Annual Screening ...
LFSA recommends annual whole-body MRI scans for all individuals with LFS to improve early cancer detection and long-term outcomes.
Rates of Intervention and Cancer Detection on Initial versus ...
Li-Fraumeni Syndrome (LFS) is a hereditary cancer predisposition syndrome with up to 90% lifetime cancer risk. Cancer screening, including ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.